Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432003 · ClinicalTrials.gov registry record
Effects of Anti-HIV Therapy on Nervous System Function
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 297
- Enrollment target
NCT00432003: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00432003 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 297 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00432003 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
Study Summary
The purpose of this study is to observe the way two different anti-HIV treatment strategies affect nerve and brain function in adults with HIV.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-07 |
What the finished NCT00432003 record still lists
NCT00432003 is an observational study that tracks outcomes without assigning an intervention. The registered 297 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00432003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00432003 about?
NCT00432003 is a clinical study titled "Effects of Anti-HIV Therapy on Nervous System Function". The purpose of this study is to observe the way two different anti-HIV treatment strategies affect nerve and brain function in adults with HIV.
What is the current status of trial NCT00432003?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2005-03. Estimated completion is 2007-07.
Who is sponsoring clinical trial NCT00432003?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
- NCT06375811 · 297 participants · Phase 3
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
- NCT07222215 · 297 participants · Phase 2
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia